|
MechanismIFNα2 modulators |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date01 Jan 1998 |
100 Clinical Results associated with Wuhan Wei'Ao Pharmaceutical Co Ltd
0 Patents (Medical) associated with Wuhan Wei'Ao Pharmaceutical Co Ltd
100 Deals associated with Wuhan Wei'Ao Pharmaceutical Co Ltd
100 Translational Medicine associated with Wuhan Wei'Ao Pharmaceutical Co Ltd